These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6214588)

  • 21. Epstein-Barr virus regulates activation and processing of the third component of complement.
    Mold C; Bradt BM; Nemerow GR; Cooper NR
    J Exp Med; 1988 Sep; 168(3):949-69. PubMed ID: 2844953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    Medof ME; Iida K; Mold C; Nussenzweig V
    J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.
    Pangburn MK; Schreiber RD; Trombold JS; Müller-Eberhard HJ
    J Exp Med; 1983 Jun; 157(6):1971-80. PubMed ID: 6222136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
    Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
    Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
    Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
    Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
    Lambris JD; Ross GD
    J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b.
    Seya T; Okada M; Nishino H; Atkinson JP
    J Biochem; 1990 Feb; 107(2):310-5. PubMed ID: 2141838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells.
    Kinoshita T; Medof ME; Hong K; Nussenzweig V
    J Exp Med; 1986 Nov; 164(5):1377-88. PubMed ID: 2430040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal anti-human C3d antibodies: stabilization of the alternative pathway C3 convertase.
    Tanuma Y; Ohi H; Hatano M
    Immunology; 1989 Dec; 68(4):445-8. PubMed ID: 2532618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of the C3b-inactivator on the cell-bound C3b.
    Law SK; Fearon DT; Levine RP
    J Immunol; 1979 Mar; 122(3):759-65. PubMed ID: 448074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cleavage of C3 by neutral proteases from granulocytes in pleural empyema.
    Suter S; Nydegger UE; Roux L; Waldvogel FA
    J Infect Dis; 1981 Dec; 144(6):499-508. PubMed ID: 6460066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum or plasma levels of C3, factor H and C3d in patients with amebic liver abscess.
    Muñoz-Espinoza LE; Salazar-Flores OG
    Arch Invest Med (Mex); 1986; 17 Suppl 1():297-301. PubMed ID: 2954516
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The generation of active fragments of complement receptor type 2 by trypsin digestion.
    Micklem K; Sim E; Sim RB
    FEBS Lett; 1985 Sep; 189(2):195-201. PubMed ID: 3876241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited proteolysis of complement protein C3b by regulatory enzyme C3b inactivator: isolation and characterization of a biologically active fragment, C3d,g.
    Seya T; Nagasawa S
    J Biochem; 1985 Jan; 97(1):373-82. PubMed ID: 3158646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T; Holers VM; Atkinson JP
    J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C3d receptors are expressed on human monocytes after in vitro cultivation.
    Inada S; Brown EJ; Gaither TA; Hammer CH; Takahashi T; Frank MM
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2351-5. PubMed ID: 6601277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
    Fischer E; Appay MD; Cook J; Kazatchkine MD
    J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
    Mold C; Kingzette M; Gewurz H
    J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.